Gene Polymorphisms Influencing Steroid Synthesis and Action
NCT ID: NCT00485186
Last Updated: 2013-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2007-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism
NCT00435513
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
NCT00494169
Inherited Reproductive Disorders
NCT01500447
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
NCT01601171
Identifying New Genetic Causes to Development Disorders
NCT03283852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
2
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Congenital Adrenal Hyperplasia
* Congenital Adrenal Hypoplasia
* Adrenal Insufficiency
* Mineralocorticoid Deficiency
* Salt-loss
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Schleswig-Holstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Felix Riepe
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul-Martin Holterhus, MD
Role: STUDY_CHAIR
University Hospital Schleswig-Holstein
Felix G Riepe, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Schleswig-Holstein
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D429/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.